Beranda › Skleroderma › Texas › Houston
Uji klinis Skleroderma di Houston, TX
9 studi untuk Skleroderma mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Menerima pesertaFase 3
- The University of Texas Health Science Center at Houston, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
- UT MD Anderson Cancer Center, Houston
Platform Clinical Study for Conquering Scleroderma
Menerima pesertaFase 2
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Menerima pesertaFase 1/2
- Nkarta Investigational Site, Houston
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Menerima pesertaFase 2
- Artiva Investigational Site Bellaire, Bellaire · 7 mi jauhnya
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
Menerima pesertaFase 2
- The University of Texas Health Science Center at Houston, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Menerima pesertaFase 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
Menerima peserta
- The University of Texas Health Science Center at Houston, Houston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Menerima pesertaFase 2
- aTyr Investigative Site, Houston
Uji klinis Skleroderma di kota lain
- New York City, NY11 studi
- Chicago, IL10 studi
- Ann Arbor, MI10 studi
- Durham, NC7 studi
- Los Angeles, CA7 studi
- Boston, MA7 studi
- Baltimore, MD6 studi
- New Orleans, LA6 studi
- Philadelphia, PA6 studi
- Pittsburgh, PA5 studi
- Dallas, TX5 studi
- Phoenix, AZ4 studi
Studi lain di Houston
- Kanker Paru Non-Sel Kecil145 studi
- Kanker Payudara126 studi
- Kanker (semua jenis)121 studi
- Kanker Metastatik104 studi
- Kanker Kolorektal102 studi
- Kanker Ovarium90 studi
- Leukemia Mieloid Akut85 studi
- Kanker Paru78 studi
- Kanker Prostat76 studi
- Kanker Endometrium68 studi
- Kanker Pankreas62 studi
- Melanoma59 studi
Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.